Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2018-05-04

Clinical Trial Update: Pulse Wave Velocity Imaging in the Assessment of PAD

View source ↗

Summary

The clinical trial evaluating pulse wave velocity imaging for peripheral arterial disease has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Unity Health Toronto | Conditions: PAD, Optical Imaging | Status: WITHDRAWN